0000950123-21-014994.txt : 20211112 0000950123-21-014994.hdr.sgml : 20211112 20211112164447 ACCESSION NUMBER: 0000950123-21-014994 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 EFFECTIVENESS DATE: 20211112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vida Ventures Advisors, LLC CENTRAL INDEX KEY: 0001831423 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20380 FILM NUMBER: 211404363 BUSINESS ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6176489100 MAIL ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001831423 XXXXXXXX 09-30-2021 09-30-2021 false Vida Ventures Advisors, LLC
40 Broad Street Suite 201 Boston MA 02109
13F HOLDINGS REPORT 028-20380 N
Jean-Philippe Kouakou-Zebouah Chief Financial Officer 857-254-9492 /s/ Jean-Philippe Kouakou-Zebouah Boston MA 11-12-2021 0 8 349152 false
INFORMATION TABLE 2 7100.xml INFORMATION TABLE FOR FORM 13F Allogene Therapeutics, Inc. Common Stock 019770106 46213 1798163 SH SOLE 1798163 0 0 Centessa Pharmaceuticals plc Ordinary Shares 152309100 65661 3931818 SH SOLE 3931818 0 0 Dyne Therapeutics, Inc. Common Stock 26818M108 48071 2960046 SH SOLE 2960046 0 0 Homology Medicines, Inc. Common Stock 438083107 6067 770845 SH SOLE 770845 0 0 Kinnate Biopharma, Inc. Common Stock 49705R105 63246 2747433 SH SOLE 2747433 0 0 Kronos Bio, Inc. Common Stock 50107A104 57961 2765314 SH SOLE 2765314 0 0 Oyster Point Pharma, Inc. Common Stock 69242L106 7585 640070 SH SOLE 640070 0 0 Praxis Precision Medicines, Inc. Common Stock 74006W108 54348 2939329 SH SOLE 2939329 0 0